skip to main
|
skip to sidebar
生技
Saturday, December 18, 2010
Virgin Market for New Bone Marrow Cancer Drug
INCY YMI ONXX
ymi vs incy
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
Resources
关注榜
生物谷
汤姆森科技信息
新药发展动态
fiercebiotech
EP Vantage
gekkowire
Labels
ALTH
(1)
AMGN
(1)
AMLN
(1)
AMRN
(1)
ARIA
(2)
ARNA
(1)
ATHX
(1)
AVEO
(1)
AVNR
(1)
BIIB
(1)
CHPI
(1)
CLDX
(3)
CMED
(1)
CSKI
(1)
DNDN
(7)
EXEL
(2)
HALO
(3)
HGSI
(5)
HLCS
(6)
ICGN
(1)
IMGN
(1)
IMMU
(2)
INCY
(15)
ISPH
(2)
ITMN
(4)
JGBO
(1)
KERX
(2)
MITI
(2)
MNKD
(4)
MYGN
(1)
NKBP
(2)
NYMX
(4)
ONTY
(1)
ONXX
(1)
OPK
(1)
OREX
(2)
PARD
(1)
PRE/VIEW
(2)
RIGL
(2)
SCR
(1)
SGEN
(11)
SPPI
(1)
SVA
(1)
TRGT
(9)
TTNP.PK
(1)
VNDA
(1)
VPHM
(2)
VRTX
(2)
VVUS
(7)
WATCHLIST
(2)
XNPT
(4)
XOMA
(1)
ZGEN
(2)
Search This Blog
Blog Archive
►
2011
(16)
►
May
(1)
►
April
(9)
►
March
(3)
►
January
(3)
▼
2010
(35)
▼
December
(6)
辉瑞引爆类风湿性关节炎市场 为了与其它3家竞争对手一争高低，全球最大的制药企业辉瑞公司将率先推出1...
风湿性关节炎药物研究出现极大希望风湿性关节炎是一种常见的疾病，大约每100人中就有1人患有风湿性关节...
Virgin Market for New Bone Marrow Cancer DrugINCY ...
Beautiful Efficacy, Wrong Pill
组合型抗癌药SGN-35取得新突破
J.P. Morgan Overweight On Human Genome Sciences (H...
►
September
(1)
►
July
(6)
►
June
(2)
►
May
(7)
►
April
(3)
►
March
(4)
►
February
(1)
►
January
(5)
►
2009
(55)
►
December
(9)
►
November
(2)
►
October
(22)
►
September
(20)
►
June
(1)
►
March
(1)
Followers
No comments:
Post a Comment